HAG
DVAX

HighPoint Advisor Group’s Dynavax Technologies DVAX Stock Holding History

HighPoint Advisor Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,000
Closed -$66K – 498
2020
Q3 		$66K Buy
16,000
+100
+0.6% +$714 0.01% 381
2020
Q2 		$132K Buy
15,900
+500
+3% +$2.53K 0.03% 329
2020
Q1 		$52K Buy
15,400
+2,700
+21% +$12.5K 0.01% 334
2019
Q4 		$77K Buy
12,700
+247
+2% +$1.32K 0.02% 355
2019
Q3 		$65K Buy
12,453
+1,009
+9% +$3.91K 0.01% 476
2019
Q2 		$38K Buy
+11,444
New +$66.3K 0.01% 479

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighPoint Advisor Group's DVAX Position: Q4 2020 in Review

HighPoint Advisor Group sold out of Dynavax Technologies (DVAX) in Q4 2020, closing a stake of 16,000 shares — an estimated $66K sold.

HighPoint Advisor Group first reported a position in DVAX in Q2 2019 and held it in 6 quarters. The position peaked at $132K in Q2 2020. 144 funds tracked by Wall St. Rank hold DVAX as of Q4 2020.

  • HighPoint Advisor Group reported no remaining Dynavax Technologies position as of Q4 2020 after selling out during the quarter.
  • HighPoint Advisor Group sold 16,000 Dynavax Technologies shares in Q4 2020, an estimated $66K.
  • HighPoint Advisor Group first reported a position in Dynavax Technologies in Q2 2019 and held it in 6 quarters.
  • HighPoint Advisor Group's Dynavax Technologies position peaked at $132K in Q2 2020.
  • 144 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2020.

Based on HighPoint Advisor Group's 13F filing for Q4 2020, filed 10 Feb 2021.